Differences between graft product and donor side effects following bone marrow or stem cell donation
暂无分享,去创建一个
N. Schmitz | M. Beksac | A. Nagler | N. Russell | A. Gratwohl | J. Szer | A. Bacigalupo | E. Gluckman | A. Buzyn | T. Ruutu | J. Apperley | J. Matcham | Marrow Transplantation | G. Favre | K. Bradstock | M. Beksaç | Jane F. Apperley | A. Gratwohl | Eliane Gluckman | Norbert Schmitz | Andrea Bacigalupo | Arnon Nagler | Nigel H. Russell | Jeff Szer | Agnès Buzyn
[1] B. Horisberger,et al. Current trends in hematopoietic stem cell transplantation in Europe. , 2002, Blood.
[2] T. Panzarella,et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. , 2002, Blood.
[3] N. Schmitz,et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. , 2002, Blood.
[4] A. Remaley,et al. Controlled study of citrate effects and response to IV calcium administration during allogeneic peripheral blood progenitor cell donation , 2002, Transfusion.
[5] M. Martelli,et al. Haploidentical stem cell transplantation for acute leukemia , 2002, International journal of hematology.
[6] M. Dew,et al. Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently? , 2001, Bone Marrow Transplantation.
[7] N. Schmitz,et al. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases , 2001, Bone Marrow Transplantation.
[8] F. Appelbaum,et al. Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation. , 2001, Blood.
[9] R Storb,et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. , 2001, The New England journal of medicine.
[10] L. Madero,et al. Clinical and economic comparison of allogeneic peripheral blood progenitor cell and bone marrow transplantation for acute lymphoblastic leukemia in children , 2000, Bone Marrow Transplantation.
[11] G. Tjønnfjord,et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow , 2000, Bone Marrow Transplantation.
[12] S. Singhal,et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial , 2000, The Lancet.
[13] J. Bourhis,et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Storb,et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor , 2000, Bone Marrow Transplantation.
[15] M. Bishop,et al. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation , 1999, Bone Marrow Transplantation.
[16] P. Anderlini,et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience , 1999, Transfusion.
[17] R. Vij,et al. Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte–colony‐stimulating factor , 1999, Transfusion.
[18] F. Aversa,et al. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor , 1999, The Lancet.
[19] D. Blaise,et al. Psychosocial aspects of haematopoietic stem cell donation for allogeneic transplantation: how family donors cope with this experience , 1999, Psycho-oncology.
[20] Y. Kodera,et al. Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors , 1999, Bone Marrow Transplantation.
[21] G. Dranitsaris,et al. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective , 1998, Bone Marrow Transplantation.
[22] R. Champlin,et al. Blood stem cell procurement: donor safety issues. , 1998, Bone marrow transplantation.
[23] N. Schmitz,et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation , 1998, Bone Marrow Transplantation.
[24] N. Schmitz,et al. Allogeneic blood stem cell transplantation: considerations for donors. , 1997, Blood.
[25] G. Pihan,et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. , 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] Y. Yazaki,et al. Malignant hyperthermia induced by general anesthesia for bone marrow harvesting , 1997, Bone Marrow Transplantation.
[27] F Locatelli,et al. Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO). , 1997, Haematologica.
[28] N. Russell,et al. STEM CELL MOBILIzATION IN NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION: ANALYSIS OF SAFETY AND FACTORS AFFECTING EFFICACY , 1996, British journal of haematology.
[29] D. Hasenclever,et al. Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks. , 1996, Bone marrow transplantation.
[30] N. Schmitz,et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients , 1996, The Lancet.
[31] S. Proctor. Allogeneic bone marrow transplantation. , 1994, Transplant immunology.
[32] P V Holland,et al. Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. , 1993, Blood.
[33] L. To,et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. , 1992, Bone marrow transplantation.
[34] Jean E. Sanders,et al. Marrow harvesting from normal donors. , 1984, Blood.